Zhengye Biotechnology Holding Limited (ZYBT) Stock Analysis & Investment Frameworks

Zhengye Biotechnology Holding Limited (ZYBT) stock analysis on Invetso. Review Zhengye Biotechnology Holding Limited’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.

Zhengye Biotechnology Holding Limited Company Overview

Zhengye Biotechnology Holding Limited Key Financial Metrics

About Zhengye Biotechnology Holding Limited

Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.

Zhengye Biotechnology Holding Limited Investment Frameworks

Invetso analyzes Zhengye Biotechnology Holding Limited (ZYBT) across the following frameworks:

Explore More ZYBT Research